Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Finasteride may cause kidney damage.

Disrupted sleep patterns can harm skin and hair cell renewal, but melatonin might help.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Fluconazole can cause hair loss, but the exact cause is unknown.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Oral zinc therapy is effective for treating acrodermatitis enteropathica.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

Modern beauty standards encourage women to remove pubic hair for aesthetic and social reasons.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Patients with traumatic brain injury need comprehensive care to improve their well-being.

The new hyaluronic acid gel is as safe and effective for lip enhancement as the existing product.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Cancer survivors need better skin care to improve their quality of life.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

Targeting Keratin 17 may help overcome cancer therapy resistance.

PCOS affects many women, causing hormonal issues and health risks, but can be managed with lifestyle changes and medication.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.